Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan

被引：0

作者：

Onda, T

Tanaka, T

Takeda, O

Kitagawa, M

Kuwabara, Y

Yamamoto, H

Iinuma, K

Shimomura, K

机构：

[1] Jikei Univ, Sch Med, Dept Obstet & Gynaecol, Tokyo 105, Japan

[2] Fuji City Hosp, Fuji, Shizuoka, Japan

[3] Natl Ohkura Hosp, Tokyo, Japan

[4] Juntendo Univ, Sch Med, Tokyo 113, Japan

[5] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan

[6] IG Clin, Tokyo, Japan

[7] Genzyme Japan KK, Tokyo, Japan

来源：

PRENATAL DIAGNOSIS | 1998年 / 18卷 / 09期

关键词：

triple-marker screening test; Down syndrome; prediction; accuracy; follow-up study;

D O I：

10.1002/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Based on 9350 pregnant Japanese women who were screened by serum triple-marker determination, accuracy of predicted risk for Down syndrome was examined using 24 Down syndrome cases detected either prenatally or postnatally. The correlation is statistically very high (r=0.98) between the predicted risks and the prevalence of Down syndrome cases. Here we emphasize that this could be accomplished only by an extensive follow-up study, implemented in our prospective intervention programme. (C) 1998 John Wiley & Sons, Ltd.

引用

页码：956 / 958

页数：3

共 50 条

[31] Use of sonographic markers to determine the risk of down syndrome in second-trimester fetuses
Benacerraf, BR
RADIOLOGY, 1996, 201 (03) : 619 - 620
[32] Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysis
Cusick, W
Buchanan, P
Hallahan, TW
Krantz, DA
Larsen, JW
Macri, JN
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) : 745 - 751
[33] Interference in the autoDELFIA® hAFP immunoassay and effect on second-trimester Down's syndrome screening
Taylor, Kevin P.
Goodburn, Sandy
Halsall, David J.
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 412 - 413
[34] First- and second-trimester screening - Detection of aneuploidies other than down syndrome
Breathnach, Fionnuala M.
Malone, Fergal D.
Lambert-Messerlian, Geralyn
Cuckle, Howard S.
Porter, T. Flint
Nyberg, David A.
Comstock, Christine H.
Saade, George R.
Berkowitz, Richard L.
Klugman, Susan
Dugoff, Lorraine
Craigo, Sabrina D.
Timor-Tritsch, Ilan E.
Carr, Stephen R.
Wolfe, Honor M.
Tripp, Tara
Bianchi, Diana W.
D'Alton, Mary E.
OBSTETRICS AND GYNECOLOGY, 2007, 110 (03): : 651 - 657
[35] Strict glycemic control in diabetic pregnancy - implications for second-trimester screening for Down syndrome
Peled, Y
Gilboa, Y
Perri, T
Shohat, M
Chen, R
Bar, J
Hod, M
Pardo, J
PRENATAL DIAGNOSIS, 2003, 23 (11) : 888 - 890
[36] The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome
Kadir, RA
Economides, DL
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 9 (04) : 244 - 247
[37] Comparing three screening strategies for combining firstand second-trimester Down syndrome markers
Skotko, Brian
OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 1170 - 1170
[38] Nuchal translucency measurement and second-trimester biochemical screening for Down's syndrome - Reply
Economides, DL
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (03) : 222 - 222
[39] Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome
Huttly, Wayne
Bestwick, Jonathan
Wald, Nicholas
PRENATAL DIAGNOSIS, 2014, 34 (04) : 406 - 407
[40] Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity
Muller, FO
Dreux, S
Dupoizat, H
Uzan, S
Dubin, MF
Oury, JF
Dingeon, B
Dommergues, M
PRENATAL DIAGNOSIS, 2003, 23 (04) : 331 - 335

← 1 2 3 4 5 →